318 related articles for article (PubMed ID: 25433820)
21. Surgical, oncological, and functional outcomes of local and radical resection after neoadjuvant chemotherapy or chemoradiotherapy for early- and mid-stage rectal cancer: a systematic review and meta-analysis.
Tan S; Ou Y; Huang S; Gao Q
Int J Colorectal Dis; 2023 May; 38(1):132. PubMed ID: 37193915
[TBL] [Abstract][Full Text] [Related]
22. Rectal cancer patients after neoadjuvant radiotherapy (30Gy/10f) with negative lymph node may not benefit from postoperative adjuvant chemotherapy: a retrospective study.
Chen P; Yao Y; Gu J
Int J Colorectal Dis; 2015 Dec; 30(12):1695-704. PubMed ID: 26278877
[TBL] [Abstract][Full Text] [Related]
23. Surveillance or Adjuvant Treatment With Chemotherapy or Radiotherapy in Stage I Seminoma: A Systematic Review and Meta-Analysis of 13 Studies.
Petrelli F; Coinu A; Cabiddu M; Ghilardi M; Borgonovo K; Lonati V; Barni S
Clin Genitourin Cancer; 2015 Oct; 13(5):428-34. PubMed ID: 25959904
[TBL] [Abstract][Full Text] [Related]
24. Correlation of pathologic complete response with survival after neoadjuvant chemotherapy in bladder cancer treated with cystectomy: a meta-analysis.
Petrelli F; Coinu A; Cabiddu M; Ghilardi M; Vavassori I; Barni S
Eur Urol; 2014 Feb; 65(2):350-7. PubMed ID: 23849998
[TBL] [Abstract][Full Text] [Related]
25. Impact of adjuvant chemotherapy after neoadjuvant radio- or radiochemotherapy for patients with locally advanced rectal cancer.
Lichthardt S; Zenorini L; Wagner J; Baur J; Kerscher A; Matthes N; Kastner C; Pelz J; Kunzmann V; Germer CT; Wiegering A
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2363-2373. PubMed ID: 28756493
[TBL] [Abstract][Full Text] [Related]
26. Is adjuvant chemotherapy really needed after curative surgery for rectal cancer patients who are node-negative after neoadjuvant chemoradiotherapy?
Kiran RP; Kirat HT; Burgess AN; Nisar PJ; Kalady MF; Lavery IC
Ann Surg Oncol; 2012 Apr; 19(4):1206-12. PubMed ID: 21935748
[TBL] [Abstract][Full Text] [Related]
27. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
[TBL] [Abstract][Full Text] [Related]
28. A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis.
Dossa F; Chesney TR; Acuna SA; Baxter NN
Lancet Gastroenterol Hepatol; 2017 Jul; 2(7):501-513. PubMed ID: 28479372
[TBL] [Abstract][Full Text] [Related]
29. Postoperative chemotherapy in patients with rectal cancer receiving preoperative radio(chemo)therapy: A meta-analysis of randomized trials comparing surgery ± a fluoropyrimidine and surgery + a fluoropyrimidine ± oxaliplatin.
Bujko K; Glimelius B; Valentini V; Michalski W; Spalek M
Eur J Surg Oncol; 2015 Jun; 41(6):713-23. PubMed ID: 25911110
[TBL] [Abstract][Full Text] [Related]
30. Increasing the Interval Between Neoadjuvant Chemoradiotherapy and Surgery in Rectal Cancer: A Meta-analysis of Published Studies.
Petrelli F; Sgroi G; Sarti E; Barni S
Ann Surg; 2016 Mar; 263(3):458-64. PubMed ID: 24263329
[TBL] [Abstract][Full Text] [Related]
31. Fluorouracil-based neoadjuvant chemoradiotherapy with or without oxaliplatin for treatment of locally advanced rectal cancer: An updated systematic review and meta-analysis.
Yang YJ; Cao L; Li ZW; Zhao L; Wu HF; Yue D; Yang JL; Zhou ZR; Liu SX
Oncotarget; 2016 Jul; 7(29):45513-45524. PubMed ID: 27322422
[TBL] [Abstract][Full Text] [Related]
32. Rectal cancers with microscopic circumferential resection margin involvement (R1 resections): Survivals, patterns of recurrence, and prognostic factors.
Gravante G; Hemingway D; Stephenson JA; Sharpe D; Osman A; Haines M; Pirjamali V; Sorge R; Yeung JM; Norwood M; Miller A; Boyle K
J Surg Oncol; 2016 Oct; 114(5):642-648. PubMed ID: 27383398
[TBL] [Abstract][Full Text] [Related]
33. [Meta-analysis of efficacy and safety on neoadjuvant therapy for rectal cancer].
Cai YH; Huang MJ; Deng YH; Wu XJ; Wang H; Yang ZL; He XS; Wang JP
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Nov; 15(11):1150-5. PubMed ID: 23172528
[TBL] [Abstract][Full Text] [Related]
34. Tumor deposits: markers of poor prognosis in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy.
Zhang LN; Xiao WW; Xi SY; OuYang PY; You KY; Zeng ZF; Ding PR; Zhang HZ; Pan ZZ; Xu RH; Gao YH
Oncotarget; 2016 Feb; 7(5):6335-44. PubMed ID: 26695441
[TBL] [Abstract][Full Text] [Related]
35. Oncologic effects of adjuvant chemotherapy in patients with ypT0-2N0 rectal cancer after neoadjuvant chemoradiotherapy and curative surgery: a meta-analysis.
Ha GW; Lee MR
Ann Surg Treat Res; 2020 Aug; 99(2):97-109. PubMed ID: 32802815
[TBL] [Abstract][Full Text] [Related]
36. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study.
Akgun E; Ozkok S; Tekin M; Yoldas T; Caliskan C; Kose T; Karabulut B; Sezak M; Elmas N; Ozutemiz O
World J Surg Oncol; 2017 Nov; 15(1):205. PubMed ID: 29166925
[TBL] [Abstract][Full Text] [Related]
37. Neoadjuvant chemoradiotherapy or chemotherapy for gastroesophageal junction adenocarcinoma: A systematic review and meta-analysis.
Petrelli F; Ghidini M; Barni S; Sgroi G; Passalacqua R; Tomasello G
Gastric Cancer; 2019 Mar; 22(2):245-254. PubMed ID: 30483986
[TBL] [Abstract][Full Text] [Related]
38. A systematic review of the predictive value of 18F-fluoro-2-deoxyglucose positron emission tomography on survival in locally advanced rectal cancer after neoadjuvant chemoradiation.
Krug B; Crott R; de Cannière L; D'Hondt L; Vander Borght T
Colorectal Dis; 2013 Nov; 15(11):e627-33. PubMed ID: 24192263
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant chemotherapy with or without pelvic radiotherapy after simultaneous surgical resection of rectal cancer with liver metastases: analysis of prognosis and patterns of recurrence.
An HJ; Yu CS; Yun SC; Kang BW; Hong YS; Lee JL; Ryu MH; Chang HM; Park JH; Kim JH; Kang YK; Kim JC; Kim TW
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):73-80. PubMed ID: 22300562
[TBL] [Abstract][Full Text] [Related]
40. Induction chemotherapy followed by neoadjuvant chemoradiotherapy and surgery for patients with locally advanced rectal cancer: a systematic review and meta-analysis.
Feng S; Yan P; Zhang Q; Li Z; Li C; Geng Y; Wang L; Zhao X; Yang Z; Cai H; Wang X
Int J Colorectal Dis; 2020 Aug; 35(8):1355-1369. PubMed ID: 32488419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
